Cargando…
Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
Many studies have demonstrated that microRNA-210 (miR-210) expression is intensively upregulated in hypoxic states and differentially regulated in most types of cancer cells. However, the clinical significance of miR-210 and its effects on the response of leukemic cells to chemotherapeutic drugs in...
Autores principales: | Mei, Yanyan, Gao, Chao, Wang, Kailing, Cui, Lei, Li, Weijing, Zhao, Xiaoxi, Liu, Feifei, Wu, Minyuan, Deng, Guoren, Ding, Wei, Jia, Hongti, Li, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317805/ https://www.ncbi.nlm.nih.gov/pubmed/24720529 http://dx.doi.org/10.1111/cas.12370 |
Ejemplares similares
-
Quantitative monitoring of minimal residual disease in childhood acute lymphoblastic leukemia using TEL‐AML1 fusion transcript as a marker
por: Zhao, Xiaoxi, et al.
Publicado: (2019) -
MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1
por: Qian, Lu, et al.
Publicado: (2016) -
DNMT3A mutations in Chinese childhood acute myeloid leukemia
por: Li, Weijing, et al.
Publicado: (2017) -
Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia
por: López-López, Elixabet, et al.
Publicado: (2014) -
Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia
por: Gao, Huixia, et al.
Publicado: (2022)